ADPT vs DFS
Adaptive Biotechnologies Corp (ADPT) versus DFS (DFS) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
DFS (DFS) common stock.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
DFS does not have a complete income-statement cache yet.
ADPT currently screens at market cap $2.69B.
Not investment advice. Open the ADPT and DFS stock pages for the full models.
Not investment advice.